Following a greenlight from the US FDA, Philips has enrolled the first patient in a trial of its newest intravascular ...

Royal Philips announced enrollment of the first patient in THOR, a United States investigational device exemption (IDE) clinica ...

THOR Integrated Device With a unique world-first ability to perform laser atherectomy and laser-based intravascular ...

Royal Philips (PHG) announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study a combined laser ...

Philips announced the first U.S. treatment using its new laser device that combines two peripheral artery disease (PAD) procedures into one.

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery ...